Cat: IPD-X14099

Recombinant Human GLP-1/GCG Protein(HEK293), C-6*His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    GLP-1/GCG

  • 简介

    GLP-1 and GCG are two proteins derived from the same precursor protein, which is encoded by the GCG-glucagon gene. The GCG protein is a counterregulatory hormone to insulin, playing a crucial role in glucose metabolism by increasing gluconeogenesis and reducing glycolysis to regulate blood glucose levels. GLP-1 protein, secreted by intestinal endocrine cells, promotes insulin secretion, regulates gastrointestinal motility, and inhibits the secretion of GCG protein. GLP-1/GCG protein, Human (HEK293, His), is a recombinant GLP-1/GCG protein expressed by HEK293 cells, with a His tag at the C-terminus, and is composed of 160 amino acids (R21-K180)[1][2][3][4][5][6][7][8][9][10].

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    GC; GLP1; GLP2; GRPP; Glicentin-Related Polypeptide; Glucagen; Oxyntomodulin; Incretin hormone

  • Species

    Human

  • Source

    HEK293

  • Tag

    C-6*His

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    P01275

  • Expression Region

    R21-K180

  • Protein Length

    Full Length of Mature Protein

  • Molecular Weight

    19-21 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

GLP-1 (glucagon-like peptide-1) and GCG (glucagon) are two key hormones in the regulation of glucose metabolism, with significant implications in diabetes and obesity treatment. GLP-1 is an incretin hormone secreted by the intestinal L-cells in response to nutrient intake, promoting insulin secretion, inhibiting glucagon release, and enhancing satiety, thus lowering blood glucose levels. In contrast, glucagon, produced by the alpha cells of the pancreas, plays a critical role in increasing blood glucose by stimulating hepatic glucose production. The imbalance between GLP-1 and glucagon signaling pathways is a central feature of type 2 diabetes, leading to hyperglycemia and related metabolic disturbances. Recent advances in biotechnology have enabled the development of recombinant proteins that mimic or modify the actions of these hormones, providing a promising therapeutic avenue for metabolic disorders. Research into the dual targeting of GLP-1 and glucagon through engineered proteins has shown potential in improving glycemic control and promoting weight loss, addressing the limitations of existing treatments. The exploration of GLP-1/GCG co-agonists or novel formulations is at the forefront of diabetes research, aiming to re-establish the balance in glucose homeostasis. Such approaches could enhance the efficacy and safety of diabetes management, paving the way for innovative strategies to tackle the increasing prevalence of metabolic diseases globally. As understanding of the physiological roles and interactions of these hormones deepens, the potential for effective therapeutic interventions continues to expand, highlighting the importance of GLP-1/GCG recombinant proteins in modern endocrinology and metabolic research.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US